Schroder Investment Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232M | Sell |
|
|||||
|
2025
Q1 | $241M | Sell |
|
|||||
|
2024
Q4 | $210M | Buy |
|
|||||
|
2024
Q3 | $168M | Buy |
|
|||||
|
2024
Q2 | $131M | Buy |
|
|||||
|
2024
Q1 | $116M | Sell |
|
|||||
|
2023
Q4 | $133M | Buy |
|
|||||
|
2023
Q3 | $113M | Buy |
|
|||||
|
2023
Q2 | $104M | Sell |
|
|||||
|
2023
Q1 | $128M | Sell |
|
|||||
|
2022
Q4 | $149M | Sell |
|
|||||
|
2022
Q3 | $111M | Sell |
|
|||||
|
2022
Q2 | $114M | Buy |
|
|||||
|
2022
Q1 | $55.9M | Buy |
|
|||||
|
2021
Q4 | $60M | Sell |
|
|||||
|
2021
Q3 | $60.9M | Sell |
|
|||||
|
2021
Q2 | $91.2M | Sell |
|
|||||
|
2021
Q1 | $110M | Sell |
|
|||||
|
2020
Q4 | $134M | Buy |
|
|||||
|
2020
Q3 | $131M | Buy |
|
|||||
|
2020
Q2 | $136M | Buy |
|
|||||
|
2020
Q1 | $131M | Sell |
|
|||||
|
2019
Q4 | $185M | Buy |
|
|||||
|
2019
Q3 | $132M | Sell |
|
|||||
|
2019
Q2 | $163M | Sell |
|
|||||
|
2019
Q1 | $180M | Sell |
|
|||||
|
2018
Q4 | $176K | Sell |
|
|||||
|
2018
Q3 | $257M | Buy |
|
|||||
|
2018
Q2 | $230M | Buy |
|
|||||
|
2018
Q1 | $216M | Sell |
|
|||||
|
2017
Q4 | $225M | Sell |
|
|||||
|
2017
Q3 | $294M | Sell |
|
|||||
|
2017
Q2 | $290M | Buy |
|
|||||
|
2017
Q1 | $245M | Buy |
|
|||||
|
2016
Q4 | $183M | Buy |
|
|||||
|
2016
Q3 | $199M | Sell |
|
|||||
|
2016
Q2 | $272M | Buy |
|
|||||
|
2016
Q1 | $284M | Buy |
|
|||||
|
2015
Q4 | $259M | Sell |
|
|||||
|
2015
Q3 | $260M | Buy |
|
|||||
|
2015
Q2 | $282M | Sell |
|
|||||
|
2015
Q1 | $317M | Buy |
|
|||||
|
2014
Q4 | $177M | Buy |
|
|||||
|
2014
Q3 | $189M | Buy |
|
|||||
|
2014
Q2 | $135M | Buy |
|
|||||
|
2014
Q1 | $63.2M | Buy |
|
|||||
|
2013
Q4 | $51M | Sell |
|
|||||
|
2013
Q3 | $165M | Sell |
|
|||||
|
2013
Q2 | $165M | Buy |
|